Compare LMB & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMB | INMD |
|---|---|---|
| Founded | 1901 | 2008 |
| Country | United States | Israel |
| Employees | 1400 | 660 |
| Industry | Engineering & Construction | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 917.0M | 854.5M |
| IPO Year | 2014 | 2018 |
| Metric | LMB | INMD |
|---|---|---|
| Price | $41.72 | $14.89 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $116.67 | $17.33 |
| AVG Volume (30 Days) | ★ 441.3K | 390.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.68 | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | ★ $646,804,000.00 | N/A |
| Revenue This Year | $15.96 | $1.74 |
| Revenue Next Year | $5.90 | $3.26 |
| P/E Ratio | $54.91 | ★ $10.11 |
| Revenue Growth | ★ 24.68 | N/A |
| 52 Week Low | $41.17 | $12.72 |
| 52 Week High | $114.95 | $16.74 |
| Indicator | LMB | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 27.25 | 44.86 |
| Support Level | N/A | $13.27 |
| Resistance Level | $84.79 | $15.28 |
| Average True Range (ATR) | 1.57 | 0.18 |
| MACD | 0.55 | -0.05 |
| Stochastic Oscillator | 15.40 | 18.00 |
Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.